• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
healthcare providers

Ahmar Urooj Zaidi, MD

Healthcare Provider
Assistant Professor, Pediatrics
Children's Hospital of Michigan
3901 Beaubien
Detroit, Michigan, United States

Ahmar Urooj Zaidi is assistant professor of pediatrics at Children’s Hospital of Michigan. He holds board certification in pediatrics from American Board of Pediatrics, 2014.

His clinical interests include sickle cell disease, benign hematology, and chronic and acquired haemolytic anemias. His research interests include novel therapies in sickle cell disease, patient reported outcomes and red blood cell disorders.

Dr Zaidi is also associated with North Star Reach as camp physician for sickle cell camp week.

He got his medical degree from Medical University of the Americas. He completed his residency in pediatrics from William Beaumont Hospital followed by fellowship in pediatric hematology/oncology from Children’s Hospital of Michigan.  


Representative Publications:

Elipsis: A Longitudinal Study of Electronic Patient-Reported Outcomes, Actigraphy and Biomarkers to Identify and Assess at-Home Vaso-Occlusive Crises in Adults and Adolescents with Sickle Cell Disease

Acute Vaso-Occlusive Pain Associated with the Onset of Menstruation Is Distinct from Dysmenorrhea in Sickle Cell Disease

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.